These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26097540)

  • 1. LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.
    Yang JA; Liu BH; Shao LM; Guo ZT; Yang Q; Wu LQ; Ji BW; Zhu XN; Zhang SQ; Li CJ; Chen QX
    Int J Clin Exp Pathol; 2015; 8(4):3580-90. PubMed ID: 26097540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressed miR-183 promoted glioblastoma radioresistance via down-regulating LRIG1.
    Fan H; Yuan R; Cheng S; Xiong K; Zhu X; Zhang Y
    Biomed Pharmacother; 2018 Jan; 97():1554-1563. PubMed ID: 29793318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
    Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
    Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation.
    Xie R; Yang H; Xiao Q; Mao F; Zhang S; Ye F; Wan F; Wang B; Lei T; Guo D
    Oncol Rep; 2013 Jan; 29(1):177-84. PubMed ID: 23124613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble LRIG2 ectodomain is released from glioblastoma cells and promotes the proliferation and inhibits the apoptosis of glioblastoma cells in vitro and in vivo in a similar manner to the full-length LRIG2.
    Xiao Q; Tan Y; Guo Y; Yang H; Mao F; Xie R; Wang B; Lei T; Guo D
    PLoS One; 2014; 9(10):e111419. PubMed ID: 25353163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
    Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
    Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
    Yan Z; Jiang J; Li F; Yang W; Xie G; Zhou C; Xia S; Cheng Y
    Oncol Rep; 2015 Apr; 33(4):1791-8. PubMed ID: 25695283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells.
    Struve N; Riedel M; Schulte A; Rieckmann T; Grob TJ; Gal A; Rothkamm K; Lamszus K; Petersen C; Dikomey E; Kriegs M
    Oncotarget; 2015 Oct; 6(32):33867-77. PubMed ID: 26418954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1.
    Chen L; Wang W; Zhu S; Jin X; Wang J; Zhu J; Zhou Y
    Exp Ther Med; 2017 Aug; 14(2):1818-1824. PubMed ID: 28810655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRIG1 improves chemosensitivity through inhibition of BCL-2 and MnSOD in glioblastoma.
    Ding J; Liu B; He Y; Yuan X; Tian D; Ji B; Wang L; Wu L; Dong H; Wang J; Zhu X; Cai Q; Zhang S; Chen Q
    Cell Biochem Biophys; 2015 Jan; 71(1):27-33. PubMed ID: 25449296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells.
    Zhang X; Song Q; Wei C; Qu J
    Cell Stress Chaperones; 2015 Jul; 20(4):631-41. PubMed ID: 25860915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRIG1 enhances cisplatin sensitivity of glioma cell lines.
    Wang X; Xiao Q; Xing X; Tian C; Zhang H; Ye F; Wan F; Wang B; Guo D; Lei T
    Oncol Res; 2012; 20(5-6):205-11. PubMed ID: 23581227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol inhibits glioma cell growth via targeting LRIG1.
    Liu L; Zhang Y; Zhu K; Song L; Tao M; Huang P; Pan Y
    J BUON; 2018; 23(2):403-409. PubMed ID: 29745084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cathepsin D (CTSD) enhances radiosensitivity of glioblastoma cells by attenuating autophagy.
    Zheng W; Chen Q; Wang C; Yao D; Zhu L; Pan Y; Zhang J; Bai Y; Shao C
    Mol Carcinog; 2020 Jun; 59(6):651-660. PubMed ID: 32253787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro.
    Cheng SQ; Fan HY; Xu X; Gao WW; Lv SG; Ye MH; Wu MJ; Shen XL; Cheng ZJ; Zhu XG; Zhang Y
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):558-563. PubMed ID: 27465333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) in HP75 pituitary adenoma cell line.
    Guo D; Han L; Shu K; Chen J; Lei T
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):91-4. PubMed ID: 17393120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRIG1, a 3p tumor suppressor, represses EGFR signaling and is a novel epigenetic silenced gene in colorectal cancer.
    Kou C; Zhou T; Han X; Zhuang H; Qian H
    Biochem Biophys Res Commun; 2015 Aug; 464(2):519-25. PubMed ID: 26159916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.
    Li F; Yang W; Guo D; Hu Z; Xu H; Ye Z
    Oncol Rep; 2011 Jun; 25(6):1629-37. PubMed ID: 21431282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of LRIG1 cDNA-induced apoptosis in human glioma cell line H4].
    Ye F; Guo DS; Niu HQ; Tao SZ; Ou YB; Lu YP; Lei T
    Ai Zheng; 2004 Oct; 23(10):1149-54. PubMed ID: 15473925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.